Latest news with #PCI
Yahoo
2 hours ago
- Business
- Yahoo
Onex stock ticks lower after Sterling Group acquires PCI stake
-- Onex Corp (TSX:ONEX) stock ticked lower by 1% on Tuesday following the announcement that The Sterling Group has agreed to acquire a majority ownership stake in Precision Concepts International, LLC (PCI) from ONCAP, Onex's lower mid-market private equity platform. Houston-based Sterling Group will partner with existing PCI investors, including ONCAP and management, to support the specialty rigid packaging solutions provider's continued growth. The financial terms of the transaction were not disclosed. PCI, headquartered in Huntersville, North Carolina, operates five manufacturing facilities across the U.S., with additional locations in Canada and Costa Rica. The company services small to mid-size companies in consumer-focused sectors including personal care, household, and food and beverage products. Upon closing of the transaction, Ken Swanson, former CEO of Sterling portfolio company Liqui-Box, will serve as Chairman of PCI's Board of Directors. Ray Grupinski will continue as PCI's Chief Executive Officer. "PCI's unique track record of elevated customer service and product quality is the perfect foundation for continued expansion," said Greg Elliott, Partner at The Sterling Group, adding that the firm looks forward to helping accelerate PCI's nationwide expansion. Ryan Mashinter, Senior Managing Director at ONCAP, noted that ONCAP will continue its journey with PCI alongside The Sterling Group as "the business enters its next chapter of growth." Evercore acted as financial advisor to The Sterling Group, while William Blair and Stifel served as financial advisors to PCI for the transaction. Related articles Onex stock ticks lower after Sterling Group acquires PCI stake Victoria's Secret Exposed: The Warning Sign Behind the Stock's 52% Collapse Buy this massive AI stock into upcoming Q2 print: Morgan Stanley Sign in to access your portfolio
Al Etihad
6 hours ago
- Business
- Al Etihad
Mubadala announces additional investment in PCI Pharma Services
15 July 2025 17:28 A. SREENIVASA REDDY (ABU DHABI)Mubadala, the Abu Dhabi-based sovereign investor, has announced additional investment in PCI Pharma Services, a global leader in contract development and manufacturing (CDMO) for complex biologics and innovative investment is being made alongside private equity firms Bain Capital, Kohlberg, and existing investor Partners strategic transaction will see PCI enter its next phase of growth with support from this strong consortium of global investors. While financial terms were not disclosed, the partnership is expected to accelerate PCI's global expansion and bolster its capabilities in biopharma a post on X, Mubadala stated: 'This marks our continued support of PCI, following our initial commitment in 2020. Over the past five years, the company has demonstrated the strength of its global capabilities and its role in advancing innovation to improve patient access and outcomes.'Mina Hamoodi, Head of Healthcare at Mubadala, commented: 'Our reinvestment in PCI reflects our deep conviction in the company's mission, leadership, and long-term potential. At this important juncture, we are delighted to welcome Bain Capital, an industry-leading healthcare investor with deep expertise in growing pharma services businesses, as a partner.'She added: 'We look forward to partnering with Bain and Kohlberg, and working closely with PCI's outstanding management team, as the company enters its next chapter of accelerated growth.'Partners Group will also continue to support PCI with a minority investment. Sujit John, Managing Director, Private Equity Health & Life at Partners Group, said: "PCI's market position, reputation, and world-class capabilities strategically position the Company to be the partner of choice for customers. We look forward to supporting PCI and the new ownership group in driving the Company into its next phase of growth.'Headquartered in Philadelphia, PCI has over 7,500 employees across 38 sites in seven countries. The company offers integrated services across the entire drug development lifecycle, and its continued investments in sterile injectables and high-potency manufacturing will strengthen pharmaceutical supply chains in the US and beyond. Source: Aletihad - Abu Dhabi
Yahoo
a day ago
- Business
- Yahoo
FSLY Stock is Slipping: Can a Steady Enterprise Base Hold the Stock?
Fastly FSLY delivers edge cloud infrastructure designed to serve, secure and accelerate digital experiences. With enterprise customers accounting for more than 90% of total revenues, future performance depends on Fastly's ability to expand adoption across its platform and maintain steady customer engagement. As more companies prioritize secure, high-performance delivery, sustained traction among large clients remains central to enterprise metrics remained stable in the first quarter. The Zacks Consensus estimate for enterprise customer count is pegged at 600 for the second quarter, up from 595 in the previous quarter. The consensus mark for enterprise revenues is pegged at $135 million, indicating 11.6% year-over-year growth.,The consensus mark for net retention is pegged at 100.46% much lower than 109.6% reported in the year-ago quarter.. A growing product suite and ecosystem integration is expected to drive platform growth. Fastly is extending its edge capabilities with AI powered bot detection, PCI compliant client-side protection and real-time cache APIs. These tools are designed to support secure, high-speed delivery for performance-sensitive workloads. Partnerships and deeper adoption across accounts like Alphabet, VMware, Shopify, Azure and AWS may help support longer-term guided second-quarter revenues between $143 million and $147 million. The Zacks Consensus Estimate for revenues is pegged at $145.07 million suggesting 9.59% year-over-year growth. Fastly faces stiff competition from Cloudflare NET and Akamai AKAM, both of which offer overlapping solutions in edge delivery and web security. Cloudflare continues to expand its programmable edge platform with integrated developer tools and bot protection, directly challenging Fastly's core offerings. Meanwhile, Akamai is strengthening its position in cloud security and compute through acquisitions and a deeper enterprise focus. Both Cloudflare and Akamai are investing in edge innovation at scale. Fastly's ability to differentiate on performance and ease of use will be key as it competes for enterprise workloads in a crowded, rapidly evolving market. FSLY shares have declined 28.9% year to date, while the broader Zacks Computer & Technology sector has increased 7.5% and the Zacks Internet Software industry has appreciated 14.1%. Image Source: Zacks Investment Research Fastly shares are currently trading with a forward 12-month price-to-sales (P/S) of 1.58X compared with the industry's 5.72X. FSLY has a Value Score of F. Image Source: Zacks Investment Research The Zacks Consensus Estimate for FSLY's 2025 loss is pegged at 9 cents per share, unchanged over the past 30 reported loss of 12 cents per share in the year-ago quarter. Fastly, Inc. price-consensus-chart | Fastly, Inc. Quote FSLY currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Akamai Technologies, Inc. (AKAM) : Free Stock Analysis Report Fastly, Inc. (FSLY) : Free Stock Analysis Report Cloudflare, Inc. (NET) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Hindustan Times
a day ago
- Business
- Hindustan Times
Private-Equity Firms Bain and Kohlberg Make Another Big Bet on Biopharma Industry
Private-equity firms Bain Capital and Kohlberg are leading a new multibillion-dollar investment in PCI Pharma Services, a company that specializes in helping biopharma companies bring new drugs to market, executives at the firms said. PREMIUM PCI plans to use the new investment to expand its services and geographic reach. The deal values PCI at $10 billion, including debt, according to people familiar with the matter. Details This will be Bain's first investment in PCI, which has been in private-equity hands for more than a decade. Kohlberg in 2020 teamed up with Abu Dhabi state-owned investment fund Mubadala to take a majority stake in the company. As part of the new deal, the executives say the two will reinvest in PCI, as will Partners Group, which first took a stake in the business in 2016. The context Bain is already invested in 40 different pharmaceutical and biotech companies and sees PCI benefiting from a number of broader trends, including the acceleration of drug development through generative artificial intelligence, according to Devin O'Reilly, the firm's head of healthcare in North America. Based in Philadelphia, PCI got its start as a drug-packaging manufacturer. It now works alongside biopharma companies throughout the yearslong process of rolling out a new drug, from creating and delivering samples for clinical trials to manufacturing, packaging and distributing the finished product. It supports 25% of the top 200 drugs, including popular GLP-1 injectable weight-loss drugs and drugs for oncology and central-nervous-system disorders. It is also backing more than 2,300 drugs in development. PCI plans to use the new investment to expand its services and geographic reach, including through acquisitions. Since Kohlberg's investment, PCI has more than doubled its revenue and quadrupled its customer base, according to PCI Chief Executive Salim Haffar. Its employee count has grown from around 3,000 to almost 8,000. Kohlberg has known it wanted to reinvest in the company since it started looking for a new investor, said Matt Jennings, a Kohlberg operating partner who serves as chairman of PCI. Write to Miriam Gottfried at Get the latest headlines from US news and global updates from Pakistan, UK, Bangladesh, and Russia get all the latest headlines in one place with including Vance Luther Boelter on Hindustan Times. Get the latest headlines from US news and global updates from Pakistan, UK, Bangladesh, and Russia get all the latest headlines in one place with including Vance Luther Boelter on Hindustan Times. See Less All Access. One Subscription. Get 360° coverage—from daily headlines to 100 year archives. E-Paper Full Archives Full Access to HT App & Website Games Already subscribed? Login SHARE THIS ARTICLE ON
Wall Street Journal
a day ago
- Business
- Wall Street Journal
Private-Equity Firms Bain and Kohlberg Make Another Big Bet on Biopharma Industry
Private-equity firms Bain Capital and Kohlberg are leading a new multibillion-dollar investment in PCI Pharma Services, a company that specializes in helping biopharma companies bring new drugs to market, executives at the firms said. The deal values PCI at $10 billion, including debt, according to people familiar with the matter.
